Does NATALIZUMAB-SZTN Cause Multiple sclerosis relapse? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Multiple sclerosis relapse have been filed in association with NATALIZUMAB-SZTN. This represents 8.5% of all adverse event reports for NATALIZUMAB-SZTN.
16
Reports of Multiple sclerosis relapse with NATALIZUMAB-SZTN
8.5%
of all NATALIZUMAB-SZTN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From NATALIZUMAB-SZTN?
Of the 16 reports, 1 (6.3%) required hospitalization.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB-SZTN. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB-SZTN Cause?
Fatigue (63)
Mobility decreased (52)
Balance disorder (31)
Headache (18)
Product substitution issue (17)
Muscular weakness (16)
Cognitive disorder (13)
Gait disturbance (13)
Dizziness (11)
Nausea (9)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
Which NATALIZUMAB-SZTN Alternatives Have Lower Multiple sclerosis relapse Risk?
NATALIZUMAB-SZTN vs NATAMYCIN
NATALIZUMAB-SZTN vs NATEGLINIDE
NATALIZUMAB-SZTN vs NAVITOCLAX
NATALIZUMAB-SZTN vs NAXITAMAB-GQGK
NATALIZUMAB-SZTN vs NEBIVOLOL